Has Linda Jager, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,029 in general payments to Linda Jager, MD across 339 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Linda Jager, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Linda Jager, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Linda Jager, MD

Family Medicine · Davenport, IANPI 1184917981

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 339 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,843 and has fallen 92.6% since, to $137 in 2025. Among family medicine clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,029in general payments, 2019–2025

Across 339 payments — averaging $20.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Organogenesis Inc.$1K
Novartis$462
AstraZeneca$452
Daiichi Sankyo Inc.$423
Seagen Inc.$339
Amgen$293
plus $4K from 54 others

What the payments were for

Food & beverage$6,81597%
Education$2143%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Organogenesis Inc.	23	$1,210
Novartis	37	$462
AstraZeneca(2 entities)	22	$452
Daiichi Sankyo Inc.	20	$423
Seagen Inc.	17	$339
Amgen	16	$293
Johnson & Johnson(2 entities)	28	$259
Exelixis Inc.	8	$257
Genentech USA, Inc.	4	$252
Bristol Myers Squibb	13	$243
Merck	11	$172
Sanofi	6	$171
E.r. Squibb & Sons, L.L.C.	9	$144
Puma Biotechnology, Inc.	8	$130
Myovant Sciences Inc.	2	$102
Angiodynamics, Inc.	1	$94
Lilly USA, LLC	5	$92
Takeda Pharmaceuticals U.S.A., Inc.	5	$91
Eisai Inc.	5	$81
Pharmacyclics LLC, An Abbvie Company	3	$80
Tactile Systems Technology Inc	5	$80
Taiho Oncology, Inc.	4	$75
Incyte Corporation	5	$74
Regeneron Healthcare Solutions, Inc.	3	$74
GSK	4	$71
Pfizer	4	$71
EUSA Pharma (US) LLC	1	$71
Smith+Nephew	4	$65
Blueprint Medicines Corporation	3	$63
Ipsen Biopharmaceuticals, Inc	4	$63
Mylan Institutional Inc.	4	$61
Pharmaessentia USA Corporation	3	$57
Astellas Pharma US Inc	3	$55
Gilead(2 entities)	4	$54
Bayer	3	$49
Convatec Inc.	2	$44
Beigene USA, Inc.	3	$43
Urgo Medical North America, LLC	2	$40
Nestle Healthcare Nutrition Inc.	3	$39
Servier Pharmaceuticals LLC	2	$38
Sobi, Inc	1	$38
EMD Serono, Inc.	2	$32
Aroa Biosurgery Incorporated	1	$27
Jazz Pharmaceuticals Inc.	2	$27
Array Biopharma Inc	2	$26
Agios Pharmaceuticals, Inc.	2	$26
Octapharma USA, Inc.	1	$20
Sanofi-aventis U.S. LLC	1	$20
Acrotech Biopharma Inc.	1	$19
Cvrx, Inc.	1	$18
ADMA Biomanufacturing LLC	1	$18
Rigel Pharmaceuticals, Inc.	1	$18
Recordati_rare_diseases_inc.	1	$17
Sun Pharmaceutical Industries Inc.	1	$17
ADC Therapeutics America, Inc.	1	$16
Helsinn Therapeutics (U.S.), Inc.	1	$15
G1 Therapeutics, Inc.	1	$15
Medline Industries LP	1	$15
AMAG Pharmaceuticals, Inc.	1	$15
CTI Biopharma Corp.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,029 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa →

Medicare billing

Part B allowed, 2024

$7,821

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Davenport

Kirk PetersonHuxley$576K
Nicholas GoetschWaterloo$525K
Stephen HarrisonClinton$249K
Thomas RossDes Moines$170K
Yogesh ShahDes Moines$159K
Leslie George PaulsenMuscatine$136K
Dylan LoweDes Moines$105K
Michael AbouassalyWest Burlington$88K
Kevin DeregnierWinterset$68K
Laura MoellerAmes$34K

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →